Please check your internet connection and try again.
# Mega-CV Duo
## Overview
Mega-CV Duo is a brand-name formulation of **Amoxicillin and Potassium Clavulanate** (co-amoxiclav). It is a combination antibiotic consisting of a penicillin-class antibiotic (amoxicillin) and a beta-lactamase inhibitor (clavulanate potassium), which protects amoxicillin from degradation by resistant bacteria.
## Primary Indications
* Community-acquired pneumonia.
* Acute bacterial sinusitis.
* Acute otitis media (AOM).
* Skin and soft tissue infections (SSTI).
* Urinary tract infections (UTIs).
* Animal/human bite wounds prophylaxis and treatment.
## Adult Dosing
* **Mild to Moderate Infections:** 875 mg/125 mg orally every 12 hours.
* **Severe Infections:** 875 mg/125 mg orally every 8 hours.
* *Note:* Maximum daily dose of clavulanate should not exceed 375 mg/day to avoid gastrointestinal toxicity.
## Pediatric Dosing
Dosing is based on the amoxicillin component.
* **General Infections:** 25 mg/kg/day to 45 mg/kg/day, divided every 12 hours.
* **Acute Otitis Media/Severe Infections:** 80–90 mg/kg/day, divided every 12 hours.
* *Caution:* Use only the 7:1 ratio (e.g., 600 mg/42.9 mg per 5 mL) for high-dose regimens to avoid excessive clavulanate intake.
## Dose Adjustments
* **Renal Impairment:** Adjustments required for CrCl < 30 mL/min. Do not use 875 mg tablets in patients with severe renal impairment (CrCl < 30 mL/min).
* **Hepatic Impairment:** Use with caution; monitor liver function periodically.
## Contraindications
* Hypersensitivity to amoxicillin, clavulanate, or any penicillin.
* History of cholestatic jaundice or hepatic dysfunction associated with amoxicillin/clavulanate therapy.
* Severe renal impairment (CrCl < 30 mL/min) for specific high-strength formulations.
## Adverse Effects
* **Common:** Diarrhea, nausea, vomiting, abdominal pain, skin rash/urticaria.
* **Serious:** Pseudomembranous colitis (*C. difficile*), hepatotoxicity (elevated LFTs, cholestatic jaundice), hypersensitivity reactions (anaphylaxis), and Stevens-Johnson syndrome.
## Key Drug Interactions
* **Methotrexate:** Increased risk of methotrexate toxicity.
* **Warfarin:** May increase INR and bleeding risk; monitor PT/INR.
* **Probenecid:** Increases and prolongs blood levels of amoxicillin.
* **Oral Contraceptives:** May decrease efficacy; advise an alternative method of contraception during treatment.
## Monitoring
* Renal and hepatic function (during prolonged therapy).
* Signs of hypersensitivity (rash, wheezing).
* Monitor for watery or bloody stools (possible *C. diff*).
## Clinical Pearls
* **Administration:** Take with food or a meal to minimize gastrointestinal intolerance and improve absorption.
* **Beta-Lactamase Coverage:** Effective against *S. aureus* (MSSA), *H. influenzae*, and *M. catarrhalis*, but does not cover MRSA.
* **Ratio Matters:** The ratio of amoxicillin to clavulanate varies by preparation. Always ensure the specific strength is selected to match the desired amoxicillin dose without exceeding the maximum allowable dose of clavulanate.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical guidelines and local prescribing protocols vary widely. Always verify current prescribing information, patient-specific allergies, and renal function via local formularies or official drug references (e.g., Lexicomp, UpToDate) before prescribing or administering medication.
